Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
Clinical trial NCT05030441 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05030441
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2030-01-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.